1. Home
  2. MDA vs INDV Comparison

MDA vs INDV Comparison

Compare MDA & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDA

MDA Space Ltd. Common Shares

N/A

Current Price

$31.02

Market Cap

4.2B

ML Signal

N/A

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$37.36

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDA
INDV
Founded
1969
N/A
Country
Canada
United States
Employees
4000
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2026
2014

Fundamental Metrics

Financial Performance
Metric
MDA
INDV
Price
$31.02
$37.36
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$37.50
N/A
AVG Volume (30 Days)
608.6K
1.5M
Earning Date
05-07-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8100.00
EPS
N/A
0.69
Revenue
N/A
$1,239,000,000.00
Revenue This Year
$12.11
N/A
Revenue Next Year
$11.03
N/A
P/E Ratio
N/A
$22.82
Revenue Growth
N/A
4.29
52 Week Low
$23.23
$10.91
52 Week High
$37.45
$39.33

Technical Indicators

Market Signals
Indicator
MDA
INDV
Relative Strength Index (RSI) 46.95 72.47
Support Level $23.23 $32.43
Resistance Level $33.75 $37.83
Average True Range (ATR) 1.72 1.50
MACD -0.36 0.53
Stochastic Oscillator 22.54 71.67

Price Performance

Historical Comparison
MDA
INDV

About MDA MDA Space Ltd. Common Shares

MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: